OAB-039: Treatment duration and long-term outcomes with daratumumab in transplant-ineligible newly diagnosed multiple myeloma from the phase 3 MAIA study
Titel:
OAB-039: Treatment duration and long-term outcomes with daratumumab in transplant-ineligible newly diagnosed multiple myeloma from the phase 3 MAIA study
Auteur:
Moreau, Philippe Facon, Thierry Usmani, Saad Kumar, Shaji Plesner, Torben Goldschmidt, Hartmut Orlowski, Robert Perrot, Aurore Chari, Ajai Cook, Gordon Pei, Huiling Van Rampelbergh, Rian Bartlett, J Blake Uhlar, Clarissa Carson, Robin Bahlis, Nizar